Day: September 28, 2021

Silence Therapeutics to Participate in Fireside Chat at the Chardan Virtual Genetic Medicines Conference 28 September 2021 LONDON, Silence Therapeutics plc, AIM: SLN and Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the treatment of diseases with significant unmet medical need, today announced that the Company will participate in a fireside chat at the Chardan Virtual Genetic Medicines Conference on Tuesday, October 5th at 8:30 a.m. EDT / 1:30 p.m. BST. A live webcast of the fireside chat can be accessed via the Investors section of the Silence website at www.silence-therapeutics.com. An archived replay of the webcast will be available on the Company’s website following the conference. Enquiries:Silence Therapeutics plc Gem...

HMS Networks AB (publ) will release its third quarter report 2021 on Friday October 22, 2021, at 14.00 CET. On the same day, at 15.00 CET, a conference call will be held for press and analysts, where President and CEO Staffan Dahlström and CFO Joakim Nideborn present the report. The presentation will be held in English and is followed live by telephone or the internet. Slides used in the presentation will be made available on HMS’ website prior to the telephone conference. To participate in the telephone conference, please call or follow the online presentation via the link below. SE: +46 8 505 583 75UK: +44 3333 009 261US: +16 467 224 903 Link to webcast The presentation and recording of the telephone conference will be available on HMS’ website after the call. https://www.hms-networks.com/ir For more information, please contact:Staffan...

DAYTONA BEACH, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), the leading installer and distributor of insulation and building material products in the United States, announced that after a more than 42-year career in finance and over six years with TopBuild, John Peterson, will be retiring from his position as Vice President and Chief Financial Officer of the Company effective March 31, 2022. At that time, Robert (“Rob”) Kuhns, Vice President and Corporate Controller, will assume the CFO position. “I want to thank John for his leadership and many contributions to TopBuild,” said Robert Buck, President and CEO of TopBuild. “John and I have worked together for over 11 years, and I couldn’t have had a better business partner and teammate. John has played a key role in TopBuild’s growth and success and has built...

SAN DIEGO, Sept. 28, 2021 (GLOBE NEWSWIRE) — KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion battery safety and thermal management technologies, today announced that CEO Michael Mo will participate in a Fireside Chat with Alliance Global Partners (“A.G.P.”) on Thursday, September 30, 2021 at 12:00 p.m. Eastern time.The event will feature a KULR corporate presentation followed by Q&A session between CEO Michael Mo and A.G.P. Managing Director, Senior Research Analyst Jake Sekelsky. Following the Q&A session, audience members will be able to ask questions live. The event will be webcast live and available for replay here. About KULR Technology Group Inc. KULR Technology Group Inc. (NYSE American: KULR) develops, manufactures...

CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive officer, will participate in a fireside chat during the Chardan Virtual 5th Annual Genetic Medicines Conference on Tuesday, Oct. 5, 2021 at 8:00 a.m. ET. The live webcast will be available in the investor section of the company’s website at www.beamtx.com. The webcast will be archived for 60 days following the presentation. About Beam Therapeutics Beam Therapeutics (Nasdaq: BEAM) is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery...

Figure 1Surface Map – Monique Gold Trend new drillingHighlights:New results from the 2021 drill program surrounding the Former Monique Mine show good continuity of the gold zones, which are still open along strike and at depth Expansion drilling continues to return impressive results, including 21.8 g/t Au over 2.0 metres, 7.2 g/t Au over 4.1 metres, 6.5 g/t Au over 4.8 metres, 1.9 g/t Au over 10.9 metres, 1.6 g/t Au over 16.0 metres and 1.5 g/t Au over 44.8 metres between surface and 500 metres vertical depth Infill drilling results continue to confirm gold mineralization continuity, with highlights of up to 1.3 g/t Au over 35.7 metres and 0.9g/t Au over 54.0m east of the Former Monique open pit, between surface and 100 metres vertical depth Three drills active on the Val-d’Or East Project – Drill program increased...

Duet releases video depicting mechanism of action for its proprietary CpG-STAT3 inhibitors to coincide with Duet presentations at OTS Meeting NEW YORK, Sept. 28, 2021 (GLOBE NEWSWIRE) — Scopus BioPharma Inc. (Nasdaq: “SCPS”), a clinical-stage biopharmaceutical company developing transformational therapeutics for serious diseases with significant unmet medical need, announced today that Duet Therapeutics, a wholly-owned subsidiary of Scopus, will release scientific data during the 17th Annual Meeting of the Oligonucleotide Therapeutics Society. The meeting will conclude on Wednesday, September 29, 2021. Alan Horsager, Ph.D., President and Chief Executive Officer of Duet and President — Immuno-Oncology of Scopus, will present DUET-01: Bispecific Oligonucleotide Targeting TLR9 and STAT3 Signaling for B Cell Lymphoma Immunotherapy...

Figure 1Wabash property – Tr-GB1 results and IP-16 anomalyMONTREAL, Sept. 28, 2021 (GLOBE NEWSWIRE) — Kintavar Exploration Inc. (the “Corporation” or “Kintavar”) (TSX-V: KTR), is very pleased to announce new exploration results from the Cloutier area located on its Wabash property. The results include the first direct grab samples from the strongest geophysical “IP” anomaly. Follow-up over this anomaly had been a priority for this summer exploration program. TR-GB1 resultsThe IP survey that was conducted last winter had identified a very strong chargeability and resistivity anomaly (PP-16) that extended for over 1.7 km (see new release February 16, 2021). Initial attempts for trenching in the strongest portion of the anomaly encountered significant amounts of overburden or access constraints. Trench TR-GB1 was...